Simon Fraser University announced on March 3, 2020 that researchers in its Brinkman Laboratory have collaborated with U.S. researchers to analyze a new drug that can kill a wide range of superbugs. (Simon Fraser University photo)

Human trials underway after B.C. researchers analyze effects of new ‘superbug-killing compound’

Brinkman Lab in Burnaby helped analyze effects of new drug after University of Cincinnati discovery

Researchers at Simon Fraser University’s Brinkman Lab in Burnaby participated in a landmark study that tests how a new drug can kill a range of superbugs – including some bacteria now resistant to all common antibiotics.

According to a March 3 release, researchers at the University of Cincinnati discovered two inexpensive chemicals work to kill disease-causing bacteria more effectively when combined.

The U.S. researchers combined the chemicals — ethylenediaminetetraacetic acid and acidified nitrite — to create the new drug known as AB569.

ALSO READ: B.C. widow sues health authority after ‘untreatable’ superbug killed husband

SFU researchers then used computers to analyze data from bacteria treated with the new drug. The results from the study indicated the drug can kill pathogens identified by the World Health Organization as urgently requiring new treatments, and posing the greatest threat to human health.

For example, the top three “priority pathogens” include Pseudomonas aeruginosa, a type of bacteria that can cause infections in the lungs, urinary tract, or blood that is known as the leading cause of morbidity in patients with cystic fibrosis.

Erin Gill, a PhD researcher at the University of British Columbia during the study and now at the Brinkman Lab, was involved in the analysis. She told Black Press Media by phone that it was inspiring to be part of “such a large, collaborative project.”

“It’s really important work to be able to contribute to the discovery of potentially novel drugs that can help to kill bacteria, because we’re running out of them,” Gill said.

The lab’s lead database developer Geoff Winsor agreed.

“We have a growing crisis with antibiotics becoming less and less effective, and treatments are failing,” Winsor said. “That’s why it’s important to test and develop new drugs and approaches to treat disease-causing bacteria that are highly resistant to existing antibiotics.”

The new drug is currently in the first phase of human trials that are being managed by Toronto-based biotechnology firm Arch Biopartners.

“I think they’re going to have some results from that soon,” Winsor said.

ALSO READ: SFU reviewing security measures after data breach exposes personal information

Correction: This story has been updated. The University of Cincinnati was responsible for testing the new AB569 drug, not the SFU Brinkman Lab.



karissa.gall@blackpress.ca

Like us on Facebook and follow us on Twitter

SFU

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

COVID-19: Daily update on the pandemic in Surrey, White Rock and beyond

APRIL 8: White Rock mulling relief options for its taxpayers, Peace Arch Provincial Park closed

White Rock council mulls financial impacts of pandemic

City is working with other municipalities to develop aligned strategies

Celebrating Easter in Surrey, during COVID-19

Surrey’s Christian churches rise to the occasion, despite Coronavirus challenges

Surrey bus driver tests positive for COVID-19

Routes he drove have not been disclosed

COVID-19: 4 new deaths, 25 new cases but only in Vancouver Coastal, Fraser Health

A total of 1,291 people have tested positive for the novel coronavirus

Emergency COVID-19 funding now available for children with special needs

Funding to be used to help support families through uncertain times of pandemic

Revenue dip needed to qualify for wage subsidy drops to 15% in March: Trudeau

Wage subsidy would over 75% of each employee’s salary for qualifying businesses

B.C. closes all provincial parks for COVID-19 protection

Easter weekend approaches, camping already closed

Air Canada says it will apply for wage subsidy to rehire workers after cutting 16,500 jobs

Air Canada said March revenues fell by more than 30 per cent year over year

Canadians urged to include pets in their COVID-19 emergency plans

That includes plans about who will care for them if the owner is hospitalized

COVID-19: Don’t get away for Easter weekend, Dr. Bonnie Henry warns

John Horgan, Adrian Dix call 130 faith leaders as holidays approach

COVID-19 world update: Joy in Wuhan as lockdown lifted; Pope denounces profiteers

Comprehensive update of coronavirus news items from around the world

COVID-19: Trudeau says 30K ventilators on the way; 3.6M Canadians claim benefits

Canada has seen more than 17,000 cases and at least 345 deaths due to COVID-19

Most Read

l -->